BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 20717119)

  • 1. In vitro antitrypanosomal activity of 12 low-molecular-weight antibiotics and observations of structure/activity relationships.
    Iwatsuki M; Otoguro K; Ishiyama A; Namatame M; Nishihara-Tukashima A; Hashida J; Nakashima T; Masuma R; Takahashi Y; Yamada H; Omura S
    J Antibiot (Tokyo); 2010 Oct; 63(10):619-22. PubMed ID: 20717119
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro antitrypanosomal activity of five low-MW antibiotics.
    Ishiyama A; Otoguro K; Iwatsuki M; Namatame M; Nishihara-Tsukashima A; Takahashi Y; Onodera H; Yamada H; Omura S
    J Antibiot (Tokyo); 2012 Feb; 65(2):113-4. PubMed ID: 22167160
    [No Abstract]   [Full Text] [Related]  

  • 3. Promising lead compounds for novel antiprotozoals.
    Otoguro K; Iwatsuki M; Ishiyama A; Namatame M; Nishihara-Tukashima A; Shibahara S; Kondo S; Yamada H; Omura S
    J Antibiot (Tokyo); 2010 Jul; 63(7):381-4. PubMed ID: 20661239
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro and in vivo antitrypanosomal activitiy of two microbial metabolites, KS-505a and alazopeptin.
    Ishiyama A; Otoguro K; Namatame M; Nishihara A; Furusawa T; Masuma R; Shiomi K; Takahashi Y; Ichimura M; Yamada H; Omura S
    J Antibiot (Tokyo); 2008 Oct; 61(10):627-32. PubMed ID: 19168977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel pyrrolobenzoxaboroles: design, synthesis, and biological evaluation against Trypanosoma brucei.
    Wu P; Zhang J; Meng Q; Nare B; Jacobs RT; Zhou H
    Eur J Med Chem; 2014 Jun; 81():59-75. PubMed ID: 24826816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro trypanocidal activity of the anti-helminthic drug niclosamide.
    Merschjohann K; Steverding D
    Exp Parasitol; 2008 Apr; 118(4):637-40. PubMed ID: 18226810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 9- and 11-Substituted 4-azapaullones are potent and selective inhibitors of African trypanosoma.
    Maiwald F; Benítez D; Charquero D; Dar MA; Erdmann H; Preu L; Koch O; Hölscher C; Loaëc N; Meijer L; Comini MA; Kunick C
    Eur J Med Chem; 2014 Aug; 83():274-83. PubMed ID: 24973661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chalcone-benzoxaborole hybrid molecules as potent antitrypanosomal agents.
    Qiao Z; Wang Q; Zhang F; Wang Z; Bowling T; Nare B; Jacobs RT; Zhang J; Ding D; Liu Y; Zhou H
    J Med Chem; 2012 Apr; 55(7):3553-7. PubMed ID: 22360533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of Trypanosoma brucei active 1-alkyloxy and 1-benzyloxyadamantano 2-guanylhydrazones.
    Papanastasiou I; Tsotinis A; Zoidis G; Kolocouris N; Prathalingam SR; Kelly JM
    ChemMedChem; 2009 Jul; 4(7):1059-62. PubMed ID: 19422003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of halo-nitrobenzamides with potential application against human African trypanosomiasis.
    Hwang JY; Smithson D; Connelly M; Maier J; Zhu F; Guy KR
    Bioorg Med Chem Lett; 2010 Jan; 20(1):149-52. PubMed ID: 19963377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antitrypanosomal activities of three peptide antibiotics: leucinostatin A and B, alamethicin I and tsushimycin.
    Ishiyama A; Otoguro K; Iwatsuki M; Namatame M; Nishihara A; Nonaka K; Kinoshita Y; Takahashi Y; Masuma R; Shiomi K; Yamada H; Omura S
    J Antibiot (Tokyo); 2009 Jun; 62(6):303-8. PubMed ID: 19407848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanocidal activity of piperazine-linked bisbenzamidines and bisbenzamidoxime, an orally active prodrug.
    Huang TL; Bacchi CJ; Kode NR; Zhang Q; Wang G; Yartlet N; Rattendi D; Londono I; Mazumder L; Vanden Eynde JJ; Mayence A; Donkor IO
    Int J Antimicrob Agents; 2007 Dec; 30(6):555-61. PubMed ID: 17920820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evaluation of the antitrypanosomal activity of fractions of Holarrhena africana.
    Nwodo NJ; Brun R; Osadebe PO
    J Ethnopharmacol; 2007 Sep; 113(3):556-9. PubMed ID: 17728085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and structure-activity relationship of Trypanosoma brucei leucyl-tRNA synthetase inhibitors as antitrypanosomal agents.
    Ding D; Meng Q; Gao G; Zhao Y; Wang Q; Nare B; Jacobs R; Rock F; Alley MR; Plattner JJ; Chen G; Li D; Zhou H
    J Med Chem; 2011 Mar; 54(5):1276-87. PubMed ID: 21322634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From human immunodeficiency virus non-nucleoside reverse transcriptase inhibitors to potent and selective antitrypanosomal compounds.
    Venkatraj M; Ariën KK; Heeres J; Joossens J; Dirié B; Lyssens S; Michiels J; Cos P; Lewi PJ; Vanham G; Maes L; Van der Veken P; Augustyns K
    Bioorg Med Chem; 2014 Oct; 22(19):5241-8. PubMed ID: 25199582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro antitrypanosomal activity of plant terpenes against Trypanosoma brucei.
    Otoguro K; Iwatsuki M; Ishiyama A; Namatame M; Nishihara-Tukashima A; Kiyohara H; Hashimoto T; Asakawa Y; Omura S; Yamada H
    Phytochemistry; 2011 Nov; 72(16):2024-30. PubMed ID: 21843897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of 1,4-benzodiazepin-2-ones with antitrypanosomal activity.
    Spencer J; Rathnam RP; Harvey AL; Clements CJ; Clark RL; Barrett MP; Wong PE; Male L; Coles SJ; Mackay SP
    Bioorg Med Chem; 2011 Mar; 19(5):1802-15. PubMed ID: 21306904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of Trypanosoma brucei MRPA in melarsoprol susceptibility.
    Alibu VP; Richter C; Voncken F; Marti G; Shahi S; Renggli CK; Seebeck T; Brun R; Clayton C
    Mol Biochem Parasitol; 2006 Mar; 146(1):38-44. PubMed ID: 16343658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel 4-alkapolyenylpyrrolo[1,2-a]quinoxalines as antileishmanial agents--part III.
    Ronga L; Del Favero M; Cohen A; Soum C; Le Pape P; Savrimoutou S; Pinaud N; Mullié C; Daulouede S; Vincendeau P; Farvacques N; Agnamey P; Pagniez F; Hutter S; Azas N; Sonnet P; Guillon J
    Eur J Med Chem; 2014 Jun; 81():378-93. PubMed ID: 24858543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA binding affinity of bisguanidine and bis(2-aminoimidazoline) derivatives with in vivo antitrypanosomal activity.
    Dardonville C; Barrett MP; Brun R; Kaiser M; Tanious F; Wilson WD
    J Med Chem; 2006 Jun; 49(12):3748-52. PubMed ID: 16759117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.